Skip to content

CASI PHARMACEUTICALS, INC.: filings

Every CASI PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 47 filings, each linked to its SEC index.

Filing record ends 2023-04-26

The latest filing in this captured record is a 20-F filed 2023-04-26. No later filing is in the SEC companyfacts record captured on 2026-09-22. CASI PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
20-F2023-04-26fiscal FY 2022461170001558370-23-006754
10-Q2022-11-14fiscal Q3 2022461290001558370-22-017615
10-Q2022-08-12fiscal Q2 2022461250001558370-22-013418
10-Q2022-05-12fiscal Q1 202246930001558370-22-008457
10-K2022-03-28fiscal FY 2021511030001558370-22-004437
10-Q2021-11-12fiscal Q3 2021421070001558370-21-015628
10-Q2021-08-12fiscal Q2 2021431110001558370-21-011386
10-Q2021-05-13fiscal Q1 202143880001558370-21-007013
10-K2021-03-30fiscal FY 202047930001558370-21-003735
10-Q2020-11-09fiscal Q3 2020431080001104659-20-122981
10-Q2020-08-10fiscal Q2 2020441090001104659-20-092576
10-Q2020-05-11fiscal Q1 202043900001104659-20-059470
10-K2020-03-16fiscal FY 2019511020001104659-20-034018
10-Q2019-11-12fiscal Q3 2019431030001104659-19-062322
10-Q2019-08-09fiscal Q2 201935830001144204-19-038740
10-Q2019-05-15fiscal Q1 201934690001144204-19-026264
10-K2019-03-29fiscal FY 201837760001144204-19-016832
10-Q2018-11-14fiscal Q3 201828680001144204-18-059603
10-Q2018-08-14fiscal Q2 201828680001144204-18-044293
10-Q2018-05-15fiscal Q1 201827550001144204-18-028483
10-K2018-03-29fiscal FY 201728590001144204-18-017897
10-Q2017-11-14fiscal Q3 201723540001144204-17-058708
10-Q2017-08-14fiscal Q2 201720480001144204-17-042779
10-Q2017-05-15fiscal Q1 201720420001144204-17-027123
10-K2017-03-31fiscal FY 201626540001144204-17-017953
10-Q2016-11-14fiscal Q3 201621490001144204-16-133783
10-Q2016-08-15fiscal Q2 201621500001144204-16-119063
10-Q2016-05-13fiscal Q1 201621440001144204-16-101476
10-K2016-03-28fiscal FY 201526540001144204-16-090485
10-Q2015-11-13fiscal Q3 201521500001144204-15-065033
10-Q2015-08-14fiscal Q2 201521500001144204-15-049373
10-Q2015-05-15fiscal Q1 201521440001144204-15-031125
10-K2015-03-27fiscal FY 201427550001144204-15-018805
10-Q2014-11-14fiscal Q3 201420480001144204-14-068808
10-Q2014-08-14fiscal Q2 201420480001144204-14-049649
10-Q2014-05-15fiscal Q1 201419400001144204-14-030860
10-K2014-03-21fiscal FY 201328580001144204-14-017002
10-Q2013-11-14fiscal Q3 201324580001144204-13-061408
10-Q2013-08-14fiscal Q2 201325600001144204-13-045481
10-Q2013-05-15fiscal Q1 201326540001144204-13-029049
10-K2013-03-21fiscal FY 201232670001144204-13-016578
10-Q2012-11-14fiscal Q3 201228730001144204-12-062119
10-Q2012-08-14fiscal Q2 201229740001144204-12-045237
10-Q2012-05-15fiscal Q1 201228580001144204-12-029241
10-K2012-03-09fiscal FY 201128570001144204-12-013984
10-Q2011-11-14fiscal Q3 201129680001144204-11-063618
10-Q2011-08-15fiscal Q2 201130700001144204-11-046949

Inspect the source

Entity
CASI PHARMACEUTICALS, INC. / CIK 0000895051
Captured
SEC response SHA-256
a5465bb63979ec441cdd2d0b7761265dc0541f5ee25dcdffded348a960f99c09

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000895051.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))